| Advantage Speech Therapy Solutions, Llc | |
|
1209 O Connell Cir, New Lenox, IL 60451-2931 | |
| (708) 829-3434 | |
| Not Available |
| Full Name | Advantage Speech Therapy Solutions, Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 1209 O Connell Cir, New Lenox, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063011542 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Advantage Speech Therapy Solutions, Llc 1209 O Connell Cir, New Lenox, IL 60451-2931 Ph: () - | Advantage Speech Therapy Solutions, Llc 1209 O Connell Cir, New Lenox, IL 60451-2931 Ph: (708) 829-3434 |
News Archive
Dana-Farber Cancer Institute scientists and colleagues have discovered that pancreatic cancer cells' growth and spread are fueled by an unusual metabolic pathway that someday might be blocked with targeted drugs to control the deadly cancer.
Researchers at Aalto University and the University of Helsinki have succeeded for the first time ever in affecting metacognition of a tactile working memory task by combining neural pathway imaging and magnetic stimulation of the brain.
New research from King's College London has found that COVID-19 may be diagnosed on the same emergency scans intended to diagnose stroke.
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
› Verified 3 days ago
Kylie Farison, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1621 Andrea Dr, New Lenox, IL 60451 Phone: 779-435-0724 | |
Mrs. Dawn R Rodriguez, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 346 Alana Dr, New Lenox, IL 60451 Phone: 815-462-0514 Fax: 815-462-3993 | |
Ms. Catherine Anne Luebbe, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 185 S Marley Rd, New Lenox, IL 60451 Phone: 815-462-4928 | |
Samantha R Formento, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1621 Andrea Dr, New Lenox, IL 60451 Phone: 779-435-0724 | |
Jodi Andrea Frigo, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21701 Gougar Rd, New Lenox, IL 60451 Phone: 815-717-3706 | |
Sean Marino, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2125 Water Chase Dr, New Lenox, IL 60451 Phone: 708-415-8275 |